(1.25%) 5 111.34 points
(0.61%) 38 318 points
(2.23%) 15 960 points
(0.37%) $83.88
(-3.24%) $1.585
(0.35%) $2 350.70
(-0.19%) $27.30
(0.30%) $923.30
(0.36%) $0.935
(0.73%) $11.03
(0.17%) $0.801
(-0.31%) $91.89
-0.62% ¥ 2 231.00
Live Chart Being Loaded With Signals
FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan...
Stats | |
---|---|
Today's Volume | 13 700.00 |
Average Volume | 25 408.00 |
Market Cap | 23.62B |
EPS | ¥0 ( 2024-02-08 ) |
Next earnings date | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥36.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 12.24 |
ATR14 | ¥3.33 (0.15%) |
FALCO HOLDINGS Co., Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
FALCO HOLDINGS Co., Ltd. Financials
Annual | 2022 |
Revenue: | ¥46.91B |
Gross Profit: | ¥14.64B (31.22 %) |
EPS: | ¥215.22 |
FY | 2022 |
Revenue: | ¥46.91B |
Gross Profit: | ¥14.64B (31.22 %) |
EPS: | ¥215.22 |
FY | 2022 |
Revenue: | ¥50.01B |
Gross Profit: | ¥17.32B (34.64 %) |
EPS: | ¥339.00 |
FY | 2021 |
Revenue: | ¥43.61B |
Gross Profit: | ¥13.70B (31.41 %) |
EPS: | ¥178.61 |
Financial Reports:
No articles found.
FALCO HOLDINGS Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥32.00 (N/A) |
¥0 (N/A) |
¥36.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥2.00 | 2005-03-15 |
Last Dividend | ¥36.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 31 | -- |
Total Paid Out | ¥472.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.35 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.35 | |
Div. Directional Score | 6.81 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8354.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7733.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6914.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
6273.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4985.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
4200.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3397.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
2487.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
9986.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8972.T | Ex Dividend Knight | 2023-10-30 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0460 | 1.500 | 9.08 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0541 | 1.200 | 8.20 | 9.83 | [0 - 0.3] |
returnOnEquityTTM | 0.0765 | 1.500 | -0.261 | -0.391 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.30 | 0.800 | 3.49 | 2.79 | [1 - 3] |
quickRatioTTM | 1.892 | 0.800 | 3.58 | 2.86 | [0.8 - 2.5] |
cashRatioTTM | 1.171 | 1.500 | 4.61 | 6.91 | [0.2 - 2] |
debtRatioTTM | 0.0136 | -1.500 | 9.77 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 182.64 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 184.51 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 184.51 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0194 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.301 | 1.000 | 8.32 | 8.32 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0463 | 1.000 | -1.073 | -1.073 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 4.02 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 1.176 | 0.800 | 5.49 | 4.40 | [0.5 - 2] |
Total Score | 10.26 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 12.16 | 1.000 | 8.87 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0765 | 2.50 | -0.168 | -0.391 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 184.51 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.37 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 184.51 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.135 | 1.500 | -2.43 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0464 | 1.000 | -1.341 | 0 | [0.1 - 0.5] |
Total Score | 3.35 |
FALCO HOLDINGS Co., Ltd.
FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, microbiology, and radio immunoassay; genetic testing services; and genomic-based drug discovery and biotechnology drug development services. The company also provides medical information technology services; food sanitation and environmental testing services; and food related genetic testing services to food manufacturers, retailers, and restaurants. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical information systems, including @home Dr. electronic medical charts for clinics with concentrated clinical testing, as well as TASCAL for ASP, a medical support system. The company was founded in 1962 and is headquartered in Kyoto, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators